Symbols

Symbols

Aime

Products

News

Markets

Watchlist

Brokers

News/

Stock/

ABUS

ABUS News

Newswire

16:01

Arbutus Biopharma: Chardan Capital maintains Buy, PT raised to $5 from $5.

07:33

Arbutus Biopharma Reports Q3 FY22 Financial Results, $93.7M Cash Position

08:09

Arbutus Biopharma: 3 Abstracts Accepted at AASLD, AB-101 Poster of Distinction.

16:29

Arbutus Biopharma: A Clinical-Stage Biotech with a Broad Patent Portfolio and Liposomal Drug Delivery Expertise.

15:49

Lifevantage's 15min chart shows KDJ Death Cross and Bearish Marubozu signal.

View More

About ABUS

Charts

--

Sector--

Established Date--

Listing Date--

Exchange--

Full-time Employees--

Fiscal Year Ends--

Website

Security Type--

Office address

Business

Introduction

View More